Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sréter

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Orvosi Hetilap|December 22, 1999
[The role of nutrition in the pathogenesis and prevention of oncologic diseases]L Sréter
Orvosi Hetilap|August 27, 1998
[Chronic myeloproliferative diseases]L Sréter
Therapia Hungarica (English Edition)|January 1, 1991
Role of interferon in clinical practiceL Sréter, J Fehér
Acta Physiologica Hungarica|January 1, 1996
Management of hemophilias--gene therapy to come?Z Vajó, L Sréter
Neoplasma|January 1, 1974
Karyotype analysis of NK-Ly ascites lymphoma in mice by means of a reassociation techniqueG Stotz, L Sréter, K Lapis
Zeitschrift Fur Arztliche Fortbildung|October 1, 1982
[Hematologic changes in alcoholism]L Sréter, J Fehér, F Gráf
Orvosi Hetilap|September 30, 1990
[The interleukins ]L Sréter, J Fehér, P Gergely
Haematologia|December 29, 2000
Detection of a b3a3 type chimera in chronic myeloid leukemia by double hybridisation of RT-PCR productsP Páldi-Haris, L Sréter, J Földi
Acta Medica Hungarica|January 1, 1988
Serum type-III-procollagen and laminin concentration after interferon therapy in chronic myeloproliferative disordersL Sréter, M Kárteszi, J Fehér, et al.
International Journal of Tissue Reactions|January 1, 1984
Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitisJ Fehér, H Toncsev, L Sréter, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Orvosi Hetilap|December 22, 1999
[The role of nutrition in the pathogenesis and prevention of oncologic diseases]L Sréter
Orvosi Hetilap|August 27, 1998
[Chronic myeloproliferative diseases]L Sréter
Therapia Hungarica (English Edition)|January 1, 1991
Role of interferon in clinical practiceL Sréter, J Fehér
Acta Physiologica Hungarica|January 1, 1996
Management of hemophilias--gene therapy to come?Z Vajó, L Sréter
Neoplasma|January 1, 1974
Karyotype analysis of NK-Ly ascites lymphoma in mice by means of a reassociation techniqueG Stotz, L Sréter, K Lapis
Zeitschrift Fur Arztliche Fortbildung|October 1, 1982
[Hematologic changes in alcoholism]L Sréter, J Fehér, F Gráf
Orvosi Hetilap|September 30, 1990
[The interleukins ]L Sréter, J Fehér, P Gergely
Haematologia|December 29, 2000
Detection of a b3a3 type chimera in chronic myeloid leukemia by double hybridisation of RT-PCR productsP Páldi-Haris, L Sréter, J Földi
Acta Medica Hungarica|January 1, 1988
Serum type-III-procollagen and laminin concentration after interferon therapy in chronic myeloproliferative disordersL Sréter, M Kárteszi, J Fehér, et al.
International Journal of Tissue Reactions|January 1, 1984
Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitisJ Fehér, H Toncsev, L Sréter, et al.
Pageof 3